We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+7.33%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.44B
AUM Growth
+$259M
(+4.2%)
Cap. Flow
+$227M
Cap. Flow
% of AUM
3.52%
Top 10 Holdings %
Top 10 Hldgs %
34.31%
Holding
1,318
New
461
Increased
339
Reduced
236
Closed
232
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$330M |
| 2 |
Brookdale Senior Living
BKD
|
+$93.7M |
| 3 |
Tenet Healthcare
THC
|
+$85.2M |
| 4 |
ENDP
Endo International plc
ENDP
|
+$70.6M |
| 5 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$64.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$206M |
| 2 |
CVS Health
CVS
|
+$122M |
| 3 |
Teva Pharmaceutical Industries Limited
TEVA
|
+$102M |
| 4 |
McKesson
MCK
|
+$80.6M |
| 5 |
Pacira BioSciences
PCRX
|
+$45.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 53.08% |
| 2 | Miscellaneous | 9.89% |
| 3 | Energy | 6.47% |
| 4 | Consumer Discretionary | 5.67% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
PUT
AstraZeneca
AZN
$252B
| $1.05M | 0.02% |
+231,300
| New | +$16.7M |
|
|
RTN
502
DELISTED
Raytheon Company
RTN
| $1.03M | 0.02% |
11,163
-40,840
| -79% | -$3.96M |
|
503
Progressive
PGR
$126B
| $1.03M | 0.02% |
+40,559
| New | +$1M |
|
504
Allstate
ALL
$64.1B
| $1.02M | 0.02% |
17,333
+11,583
| +201% | +$668K |
|
505
MediWound
MDWD
$170M
| $1.01M | 0.02% |
+12,695
| New | +$1.03M |
|
506
iShares Mortgage Real Estate ETF
REM
$485M
| $1.01M | 0.02% |
+20,000
| New | +$1M |
|
|
MM
507
DELISTED
MILLENNIAL MEDIA INC COM STK (DE)
MM
| $1.01M | 0.02% |
202,430
+89,390
| +79% | +$452K |
|
508
Aon
AON
$63.4B
| $1M | 0.02% |
11,122
+423
| +4% | +$36.6K |
|
509
Phillips 66
PSX
$106B
| $1M | 0.02% |
12,464
+9,219
| +284% | +$759K |
|
510
State Street Energy Select Sector SPDR ETF
XLE
$42B
| $1M | 0.02% |
+20,000
| New | +$947K |
|
511
Gilead Sciences
GILD
$183B
| $1M | 0.02% |
12,066
-50
| -0.4% | -$3.89K |
|
|
MHFI
512
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
| $989K | 0.02% |
+11,912
| New | +$939K |
|
|
CAVM
513
DELISTED
Cavium, Inc.
CAVM
| $989K | 0.02% |
+19,915
| New | +$916K |
|
514
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$794B
| $987K | 0.02% |
255,000
+55,400
| +28% | +$10.5M |
|
515
APA Corp
APA
$15.7B
| $981K | 0.02% |
+9,754
| New | +$883K |
|
516
State Street Industrial Select Sector SPDR ETF
XLI
$30.5B
| $973K | 0.02% |
18,000
+9,000
| +100% | +$481K |
|
517
Nucor
NUE
$58.8B
| $971K | 0.02% |
+19,717
| New | +$1.01M |
|
|
FRED
518
DELISTED
Fred's Inc
FRED
| $969K | 0.02% |
63,355
+61,987
| +4,531% | +$1.04M |
|
519
Alcoa
AA
$12.2B
| $964K | 0.02% |
26,952
-287,236
| -91% | -$9.42M |
|
520
Designer Brands
DBI
$310M
| $964K | 0.02% |
+34,505
| New | +$1.09M |
|
|
SPLS
521
DELISTED
Staples Inc
SPLS
| $964K | 0.02% |
88,975
+34,401
| +63% | +$408K |
|
|
TC
522
DELISTED
Thompson Creek Metals Company Inc. Ordinary Shares (Canada)
TC
| $962K | 0.01% |
+325,000
| New | +$896K |
|
523
Regions Financial
RF
$24.2B
| $961K | 0.01% |
90,500
-110,324
| -55% | -$1.15M |
|
|
AGRX
524
DELISTED
Agile Therapeutics
AGRX
| $943K | 0.01% |
+54
| New | +$781K |
|
|
ZOES
525
DELISTED
Zoe's Kitchen, Inc.
ZOES
| $942K | 0.01% |
+27,402
| New | +$794K |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q2 2014 Portfolio in Review
As of Q2 2014, Visium Asset Management held 1,318 positions worth $6.44B, up 4.2% from $6.18B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Visium Asset Management deployed $227M of net new capital in Q2 2014, opening 461 new positions and adding to 339 existing holdings. Its largest new stake was NPS PHARMACEUTICALS INC: 1,020,622 shares worth $33.7M.
By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 56% a quarter earlier, followed by Miscellaneous and Energy.
On the sell side, the largest reduction was Bausch Health, an estimated $206M trimmed.
- Visium Asset Management's largest Q2 2014 buy was NPS PHARMACEUTICALS INC: 1,020,622 shares worth $33.7M.
- Visium Asset Management added most to Allergan Inc in Q2 2014, an estimated $330M increase.
- Visium Asset Management's biggest Q2 2014 reduction was Bausch Health, cutting an estimated $206M.
- Visium Asset Management fully exited QUESTCOR PHARMA INC in Q2 2014, selling an estimated $34M.
- Visium Asset Management's ten largest holdings make up 34% of its $6.44B portfolio in Q2 2014.
- Visium Asset Management opened 461 new positions and closed 232 in Q2 2014.
- Visium Asset Management's portfolio value rose 4.2% quarter-over-quarter to $6.44B.
Based on Visium Asset Management's 13F filing for Q2 2014, filed 14 Aug 2014.